莲花健康(600186) - 2024 Q2 - 季度业绩预告
LHGLHG(SH:600186)2024-07-08 12:03

Financial Performance - The company expects a net profit attributable to shareholders of 101 million to 110 million yuan for the first half of 2024, an increase of 50.84 million to 59.84 million yuan compared to the same period last year, representing a year-on-year growth of 101.36% to 119.30%[1]. - The net profit attributable to shareholders after deducting non-recurring gains and losses is expected to be 102 million to 111 million yuan, an increase of 51.36 million to 60.36 million yuan year-on-year, reflecting a growth of 101.43% to 119.21%[1]. - The company achieved a net profit of 50.16 million yuan in the same period last year, and a net profit of 50.64 million yuan after deducting non-recurring gains and losses[11]. Operational Efficiency - The company has implemented cost reduction and efficiency enhancement measures, resulting in high operational efficiency[4]. - The company has effectively reduced the procurement costs of major raw materials through improved market analysis and procurement strategies[16]. Marketing and Sales Strategy - The company has strengthened its brand revival strategy, optimizing marketing network layout and enhancing brand promotion, leading to significant growth in product sales and revenue in the first half of 2024[12]. - The sales net profit margin has improved year-on-year[12]. Financial Reporting - The financial data provided is preliminary and has not been audited, with the final figures to be disclosed in the official half-year report[13].